chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Angiogram pulmonary abnormal, Auscultation, Brain natriuretic peptide increased, COVID-19
Clinical narrative: Patient off oxygen all day, doing well and able to ambulate without hypoxemia.  Suspect hypoxemia overnight d/t undiagnosed OSA.  Discharge with 10 total days of decadron for acute resp failure d/t COVID.  F/u with PCP        Patient is a 83 y.o. male patient of MD with history of PAF on amiodarone, Eliquis, CHF, CAD s/p stents, hypertension, hyperlipidemia, osteoporosis, peripheral neuropathy, BPH, prior CLL, GERD, who presented emergency department with shortness of breath, cough.      Acute hypoxemic respiratory failure d/t below  COVID 19 pneumonia  P/w increased SOB and cough ongoing for several days PTA   Initial COVID test + 11/28, still positive 12/8 on admission   Required up to 10L NRB on admission, otherwise HDS CTPA negative for PE with multifocal pneumonia noted.   Inflammatory markers elevated  Continue with decadron, LDT (12/21)   Continue to titrate oxygen to maintain SpO2 > 88%, transitioned to RA on my evaluation  Discontinue rocephin/azithro given normal PCT and viral pneumonia     Acute decompensated HFpEF  Patient without obvious peripheral edema   CT with trace bilateral pleural effusions  Echo with LVEF 65%, normal diastolic dysfunction.   BNP 1400, much higher than prior.   Not overtly volume overloaded, lungs clear to auscultation. Continue home oral diuresis.   Evaluated by cardiology, no further recommendations    Probable OSA  Will need pulm referral for sleep study on discharge    3.  Paroxysmal Atrial Fibrillation -CHADSVASC 4, rate controlled, resume home Eliquis, amiodarone.   4.  History of CAD, HTN, HLD -Stable, no acute changes, denies chest pain, negative troponin Will resume home medications.    5. Hx CLL  -With known history of multifocal low-grade lymphoma, -CTA showed bilateral mediastinal, supraclavicular, subcarinal/hilar, paraesophageal lymphadenopathy  -Approximately 4 to 6 weeks ago discontinued from taking acalabrutinib  -Does have appointment coming up with Dr., oncology on 1/3/2023   6.  Chronic conditions include: BPH, GERD, osteoarthritis, thoracic aortic aneurysm
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Cardiac failure, Cardiac failure acute, Computerised tomogram thorax abnormal, Cough
Clinical narrative: Patient off oxygen all day, doing well and able to ambulate without hypoxemia.  Suspect hypoxemia overnight d/t undiagnosed OSA.  Discharge with 10 total days of decadron for acute resp failure d/t COVID.  F/u with PCP        Patient is a 83 y.o. male patient of MD with history of PAF on amiodarone, Eliquis, CHF, CAD s/p stents, hypertension, hyperlipidemia, osteoporosis, peripheral neuropathy, BPH, prior CLL, GERD, who presented emergency department with shortness of breath, cough.      Acute hypoxemic respiratory failure d/t below  COVID 19 pneumonia  P/w increased SOB and cough ongoing for several days PTA   Initial COVID test + 11/28, still positive 12/8 on admission   Required up to 10L NRB on admission, otherwise HDS CTPA negative for PE with multifocal pneumonia noted.   Inflammatory markers elevated  Continue with decadron, LDT (12/21)   Continue to titrate oxygen to maintain SpO2 > 88%, transitioned to RA on my evaluation  Discontinue rocephin/azithro given normal PCT and viral pneumonia     Acute decompensated HFpEF  Patient without obvious peripheral edema   CT with trace bilateral pleural effusions  Echo with LVEF 65%, normal diastolic dysfunction.   BNP 1400, much higher than prior.   Not overtly volume overloaded, lungs clear to auscultation. Continue home oral diuresis.   Evaluated by cardiology, no further recommendations    Probable OSA  Will need pulm referral for sleep study on discharge    3.  Paroxysmal Atrial Fibrillation -CHADSVASC 4, rate controlled, resume home Eliquis, amiodarone.   4.  History of CAD, HTN, HLD -Stable, no acute changes, denies chest pain, negative troponin Will resume home medications.    5. Hx CLL  -With known history of multifocal low-grade lymphoma, -CTA showed bilateral mediastinal, supraclavicular, subcarinal/hilar, paraesophageal lymphadenopathy  -Approximately 4 to 6 weeks ago discontinued from taking acalabrutinib  -Does have appointment coming up with Dr., oncology on 1/3/2023   6.  Chronic conditions include: BPH, GERD, osteoarthritis, thoracic aortic aneurysm
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Diastolic dysfunction, Dyspnoea, Echocardiogram abnormal, Ejection fraction, Hilar lymphadenopathy
Clinical narrative: Patient off oxygen all day, doing well and able to ambulate without hypoxemia.  Suspect hypoxemia overnight d/t undiagnosed OSA.  Discharge with 10 total days of decadron for acute resp failure d/t COVID.  F/u with PCP        Patient is a 83 y.o. male patient of MD with history of PAF on amiodarone, Eliquis, CHF, CAD s/p stents, hypertension, hyperlipidemia, osteoporosis, peripheral neuropathy, BPH, prior CLL, GERD, who presented emergency department with shortness of breath, cough.      Acute hypoxemic respiratory failure d/t below  COVID 19 pneumonia  P/w increased SOB and cough ongoing for several days PTA   Initial COVID test + 11/28, still positive 12/8 on admission   Required up to 10L NRB on admission, otherwise HDS CTPA negative for PE with multifocal pneumonia noted.   Inflammatory markers elevated  Continue with decadron, LDT (12/21)   Continue to titrate oxygen to maintain SpO2 > 88%, transitioned to RA on my evaluation  Discontinue rocephin/azithro given normal PCT and viral pneumonia     Acute decompensated HFpEF  Patient without obvious peripheral edema   CT with trace bilateral pleural effusions  Echo with LVEF 65%, normal diastolic dysfunction.   BNP 1400, much higher than prior.   Not overtly volume overloaded, lungs clear to auscultation. Continue home oral diuresis.   Evaluated by cardiology, no further recommendations    Probable OSA  Will need pulm referral for sleep study on discharge    3.  Paroxysmal Atrial Fibrillation -CHADSVASC 4, rate controlled, resume home Eliquis, amiodarone.   4.  History of CAD, HTN, HLD -Stable, no acute changes, denies chest pain, negative troponin Will resume home medications.    5. Hx CLL  -With known history of multifocal low-grade lymphoma, -CTA showed bilateral mediastinal, supraclavicular, subcarinal/hilar, paraesophageal lymphadenopathy  -Approximately 4 to 6 weeks ago discontinued from taking acalabrutinib  -Does have appointment coming up with Dr., oncology on 1/3/2023   6.  Chronic conditions include: BPH, GERD, osteoarthritis, thoracic aortic aneurysm
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia, Inflammatory marker increased, Lymphadenopathy, Lymphadenopathy mediastinal, Obstructive sleep apnoea syndrome
Clinical narrative: Patient off oxygen all day, doing well and able to ambulate without hypoxemia.  Suspect hypoxemia overnight d/t undiagnosed OSA.  Discharge with 10 total days of decadron for acute resp failure d/t COVID.  F/u with PCP        Patient is a 83 y.o. male patient of MD with history of PAF on amiodarone, Eliquis, CHF, CAD s/p stents, hypertension, hyperlipidemia, osteoporosis, peripheral neuropathy, BPH, prior CLL, GERD, who presented emergency department with shortness of breath, cough.      Acute hypoxemic respiratory failure d/t below  COVID 19 pneumonia  P/w increased SOB and cough ongoing for several days PTA   Initial COVID test + 11/28, still positive 12/8 on admission   Required up to 10L NRB on admission, otherwise HDS CTPA negative for PE with multifocal pneumonia noted.   Inflammatory markers elevated  Continue with decadron, LDT (12/21)   Continue to titrate oxygen to maintain SpO2 > 88%, transitioned to RA on my evaluation  Discontinue rocephin/azithro given normal PCT and viral pneumonia     Acute decompensated HFpEF  Patient without obvious peripheral edema   CT with trace bilateral pleural effusions  Echo with LVEF 65%, normal diastolic dysfunction.   BNP 1400, much higher than prior.   Not overtly volume overloaded, lungs clear to auscultation. Continue home oral diuresis.   Evaluated by cardiology, no further recommendations    Probable OSA  Will need pulm referral for sleep study on discharge    3.  Paroxysmal Atrial Fibrillation -CHADSVASC 4, rate controlled, resume home Eliquis, amiodarone.   4.  History of CAD, HTN, HLD -Stable, no acute changes, denies chest pain, negative troponin Will resume home medications.    5. Hx CLL  -With known history of multifocal low-grade lymphoma, -CTA showed bilateral mediastinal, supraclavicular, subcarinal/hilar, paraesophageal lymphadenopathy  -Approximately 4 to 6 weeks ago discontinued from taking acalabrutinib  -Does have appointment coming up with Dr., oncology on 1/3/2023   6.  Chronic conditions include: BPH, GERD, osteoarthritis, thoracic aortic aneurysm
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Pleural effusion, Pneumonia, Pneumonia viral, SARS-CoV-2 test positive, Troponin normal
Clinical narrative: Patient off oxygen all day, doing well and able to ambulate without hypoxemia.  Suspect hypoxemia overnight d/t undiagnosed OSA.  Discharge with 10 total days of decadron for acute resp failure d/t COVID.  F/u with PCP        Patient is a 83 y.o. male patient of MD with history of PAF on amiodarone, Eliquis, CHF, CAD s/p stents, hypertension, hyperlipidemia, osteoporosis, peripheral neuropathy, BPH, prior CLL, GERD, who presented emergency department with shortness of breath, cough.      Acute hypoxemic respiratory failure d/t below  COVID 19 pneumonia  P/w increased SOB and cough ongoing for several days PTA   Initial COVID test + 11/28, still positive 12/8 on admission   Required up to 10L NRB on admission, otherwise HDS CTPA negative for PE with multifocal pneumonia noted.   Inflammatory markers elevated  Continue with decadron, LDT (12/21)   Continue to titrate oxygen to maintain SpO2 > 88%, transitioned to RA on my evaluation  Discontinue rocephin/azithro given normal PCT and viral pneumonia     Acute decompensated HFpEF  Patient without obvious peripheral edema   CT with trace bilateral pleural effusions  Echo with LVEF 65%, normal diastolic dysfunction.   BNP 1400, much higher than prior.   Not overtly volume overloaded, lungs clear to auscultation. Continue home oral diuresis.   Evaluated by cardiology, no further recommendations    Probable OSA  Will need pulm referral for sleep study on discharge    3.  Paroxysmal Atrial Fibrillation -CHADSVASC 4, rate controlled, resume home Eliquis, amiodarone.   4.  History of CAD, HTN, HLD -Stable, no acute changes, denies chest pain, negative troponin Will resume home medications.    5. Hx CLL  -With known history of multifocal low-grade lymphoma, -CTA showed bilateral mediastinal, supraclavicular, subcarinal/hilar, paraesophageal lymphadenopathy  -Approximately 4 to 6 weeks ago discontinued from taking acalabrutinib  -Does have appointment coming up with Dr., oncology on 1/3/2023   6.  Chronic conditions include: BPH, GERD, osteoarthritis, thoracic aortic aneurysm
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient received Covid Monovalent for 3rd dose.  Should have rec'd Covid Bivalent.  No treatment given.  No adverse outcome.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Diagnosed and hospitalized with COVID while vaccinated
Age: 94.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Asthenia, Atelectasis, Bladder catheterisation, C-reactive protein increased
Clinical narrative: The patient is a 94 y.o. male with history of PAF, CHB, HLD presented to the hospital with generalized weakness   Acute Hypoxic Respiratory Failure COVID-19 Infection  Aspiration Pneumonitis Presented to the hospital with sore throat and generalized weakness for 3 days Was on RA on admission, CXR was non-acute, afebrile Episodes of vomiting early morning 12/9, and then subsequently on oxygen at 4L and then up to ventimask. Down to 5L 12/10 Repeat CXR with diminished lung volumes, interval progression of bibasilar atelectatic/consolidative changes since prior study.  CRP elevated and trending up on repeat Given hypoxia started on dexamethasone and remdesivir 12/9 Had worsening O2 needs so was started on antibiotics for possible aspiration Quickly improved in < 24 hours and now off oxygen. Stop remdesivir Procalcitonin normal, will stop antibiotics Continue decadron x10 total days   Generalized weakness + his leg gave up and unable to use his walker, keep sliding, did not fall  Wife at bedside, unable to take care of him at this level and requested SNF PT/OT consulted SW consult Discharge to SNF   Urinary Retention Patient incontinent at baseline Having some difficulty urinating 12/10 Underwent straight cath x 1 Now urinating better Continue to monitor   PAF CHB s/p pacemaker On warfarin Pharmacy consulted to dose warfarin   Goals of care with advanced directives Patient elected to be DNRCCA-DNI
Age: 94.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Chest X-ray abnormal, Dysuria, Gait disturbance, Hypoxia
Clinical narrative: The patient is a 94 y.o. male with history of PAF, CHB, HLD presented to the hospital with generalized weakness   Acute Hypoxic Respiratory Failure COVID-19 Infection  Aspiration Pneumonitis Presented to the hospital with sore throat and generalized weakness for 3 days Was on RA on admission, CXR was non-acute, afebrile Episodes of vomiting early morning 12/9, and then subsequently on oxygen at 4L and then up to ventimask. Down to 5L 12/10 Repeat CXR with diminished lung volumes, interval progression of bibasilar atelectatic/consolidative changes since prior study.  CRP elevated and trending up on repeat Given hypoxia started on dexamethasone and remdesivir 12/9 Had worsening O2 needs so was started on antibiotics for possible aspiration Quickly improved in < 24 hours and now off oxygen. Stop remdesivir Procalcitonin normal, will stop antibiotics Continue decadron x10 total days   Generalized weakness + his leg gave up and unable to use his walker, keep sliding, did not fall  Wife at bedside, unable to take care of him at this level and requested SNF PT/OT consulted SW consult Discharge to SNF   Urinary Retention Patient incontinent at baseline Having some difficulty urinating 12/10 Underwent straight cath x 1 Now urinating better Continue to monitor   PAF CHB s/p pacemaker On warfarin Pharmacy consulted to dose warfarin   Goals of care with advanced directives Patient elected to be DNRCCA-DNI
Age: 94.0
Sex: M
Vaccine: COVID19-2
Symptoms: Lung consolidation, Musculoskeletal disorder, Oropharyngeal pain, Pneumonitis aspiration, Procalcitonin normal
Clinical narrative: The patient is a 94 y.o. male with history of PAF, CHB, HLD presented to the hospital with generalized weakness   Acute Hypoxic Respiratory Failure COVID-19 Infection  Aspiration Pneumonitis Presented to the hospital with sore throat and generalized weakness for 3 days Was on RA on admission, CXR was non-acute, afebrile Episodes of vomiting early morning 12/9, and then subsequently on oxygen at 4L and then up to ventimask. Down to 5L 12/10 Repeat CXR with diminished lung volumes, interval progression of bibasilar atelectatic/consolidative changes since prior study.  CRP elevated and trending up on repeat Given hypoxia started on dexamethasone and remdesivir 12/9 Had worsening O2 needs so was started on antibiotics for possible aspiration Quickly improved in < 24 hours and now off oxygen. Stop remdesivir Procalcitonin normal, will stop antibiotics Continue decadron x10 total days   Generalized weakness + his leg gave up and unable to use his walker, keep sliding, did not fall  Wife at bedside, unable to take care of him at this level and requested SNF PT/OT consulted SW consult Discharge to SNF   Urinary Retention Patient incontinent at baseline Having some difficulty urinating 12/10 Underwent straight cath x 1 Now urinating better Continue to monitor   PAF CHB s/p pacemaker On warfarin Pharmacy consulted to dose warfarin   Goals of care with advanced directives Patient elected to be DNRCCA-DNI
Age: 94.0
Sex: M
Vaccine: COVID19-2
Symptoms: Total lung capacity decreased, Urinary retention, Vomiting, Walking aid user
Clinical narrative: The patient is a 94 y.o. male with history of PAF, CHB, HLD presented to the hospital with generalized weakness   Acute Hypoxic Respiratory Failure COVID-19 Infection  Aspiration Pneumonitis Presented to the hospital with sore throat and generalized weakness for 3 days Was on RA on admission, CXR was non-acute, afebrile Episodes of vomiting early morning 12/9, and then subsequently on oxygen at 4L and then up to ventimask. Down to 5L 12/10 Repeat CXR with diminished lung volumes, interval progression of bibasilar atelectatic/consolidative changes since prior study.  CRP elevated and trending up on repeat Given hypoxia started on dexamethasone and remdesivir 12/9 Had worsening O2 needs so was started on antibiotics for possible aspiration Quickly improved in < 24 hours and now off oxygen. Stop remdesivir Procalcitonin normal, will stop antibiotics Continue decadron x10 total days   Generalized weakness + his leg gave up and unable to use his walker, keep sliding, did not fall  Wife at bedside, unable to take care of him at this level and requested SNF PT/OT consulted SW consult Discharge to SNF   Urinary Retention Patient incontinent at baseline Having some difficulty urinating 12/10 Underwent straight cath x 1 Now urinating better Continue to monitor   PAF CHB s/p pacemaker On warfarin Pharmacy consulted to dose warfarin   Goals of care with advanced directives Patient elected to be DNRCCA-DNI
Age: 1.25
Sex: M
Vaccine: DTAP, HIBV
Symptoms: Inflammation, Vaccination site erythema, Vaccination site reaction, Vaccination site swelling
Clinical narrative: Pt her today with mother due to vaccine reaction to left leg after receiving PedvaxHib 12/27/22. Mother states he developed an inflammatory reaction last evening about 2000. No fever, eating/drinking the same- no irritability. Left thigh shows reddened swollen area about 9cmX7cm. Tylenol  given last night about 2300- baby fell asleep.  Provider assessed and offeredRx: Clindamycin pediatric 75mg/5ml       Take 8mg orally every 8 hours with food for 7days ***** Provider call number given to patient with concerns
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Acute respiratory failure, Anticoagulant therapy, Atrial fibrillation, Bradycardia
Clinical narrative: Patient is a 68 y.o. male.   Report on admission: patient is a 68 y.o. male presenting from home with c/o  According to patient he has been having dyspnea for past week that got worse since this morning, associated with dry cough, generalized abdominal pain, subjective fever, substernal chest pain.  Patient's wife mentions that he has been declining for past month.  He is not getting out of bed as much.  Patient denies headache, visual disturbances, nausea, vomiting, constipation, dysuria, increased peripheral swelling, focal numbness/weakness.   Hospital course as below.  Cardiology followed patient during stay.  Patient improved with medical treatment.  Patient discharged home in stable condition.  Home health care services arranged, patient declined SNF placement.   1.  COVID, +12/3: -Chest x-ray no pneumonia -Patient requiring oxygen, receiving Decadron remdesivir -Decadron -Remdesivir -Eliquis DVT prophylaxis  2.  Acute hypoxic respiratory failure: -In the setting of above -Wean oxygen as able  3.  New onset A. fib with RVR: -Cardiology following -12/3 echo EF 65%, grade 1 diastolic dysfunction -lopressor dc in setting of bradycardia -Started on Eliquis -30-day event monitor with cardiology  4.  Hypokalemia: -Replace  5.  Generalized weakness: -PT/OT -Social work for discharge needs  6. Obesity
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Chest pain, Cough, Diastolic dysfunction
Clinical narrative: Patient is a 68 y.o. male.   Report on admission: patient is a 68 y.o. male presenting from home with c/o  According to patient he has been having dyspnea for past week that got worse since this morning, associated with dry cough, generalized abdominal pain, subjective fever, substernal chest pain.  Patient's wife mentions that he has been declining for past month.  He is not getting out of bed as much.  Patient denies headache, visual disturbances, nausea, vomiting, constipation, dysuria, increased peripheral swelling, focal numbness/weakness.   Hospital course as below.  Cardiology followed patient during stay.  Patient improved with medical treatment.  Patient discharged home in stable condition.  Home health care services arranged, patient declined SNF placement.   1.  COVID, +12/3: -Chest x-ray no pneumonia -Patient requiring oxygen, receiving Decadron remdesivir -Decadron -Remdesivir -Eliquis DVT prophylaxis  2.  Acute hypoxic respiratory failure: -In the setting of above -Wean oxygen as able  3.  New onset A. fib with RVR: -Cardiology following -12/3 echo EF 65%, grade 1 diastolic dysfunction -lopressor dc in setting of bradycardia -Started on Eliquis -30-day event monitor with cardiology  4.  Hypokalemia: -Replace  5.  Generalized weakness: -PT/OT -Social work for discharge needs  6. Obesity
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Echocardiogram abnormal, Ejection fraction normal, Electrocardiogram ambulatory, General physical health deterioration
Clinical narrative: Patient is a 68 y.o. male.   Report on admission: patient is a 68 y.o. male presenting from home with c/o  According to patient he has been having dyspnea for past week that got worse since this morning, associated with dry cough, generalized abdominal pain, subjective fever, substernal chest pain.  Patient's wife mentions that he has been declining for past month.  He is not getting out of bed as much.  Patient denies headache, visual disturbances, nausea, vomiting, constipation, dysuria, increased peripheral swelling, focal numbness/weakness.   Hospital course as below.  Cardiology followed patient during stay.  Patient improved with medical treatment.  Patient discharged home in stable condition.  Home health care services arranged, patient declined SNF placement.   1.  COVID, +12/3: -Chest x-ray no pneumonia -Patient requiring oxygen, receiving Decadron remdesivir -Decadron -Remdesivir -Eliquis DVT prophylaxis  2.  Acute hypoxic respiratory failure: -In the setting of above -Wean oxygen as able  3.  New onset A. fib with RVR: -Cardiology following -12/3 echo EF 65%, grade 1 diastolic dysfunction -lopressor dc in setting of bradycardia -Started on Eliquis -30-day event monitor with cardiology  4.  Hypokalemia: -Replace  5.  Generalized weakness: -PT/OT -Social work for discharge needs  6. Obesity
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Hypokalaemia, Mobility decreased, Obesity, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Patient is a 68 y.o. male.   Report on admission: patient is a 68 y.o. male presenting from home with c/o  According to patient he has been having dyspnea for past week that got worse since this morning, associated with dry cough, generalized abdominal pain, subjective fever, substernal chest pain.  Patient's wife mentions that he has been declining for past month.  He is not getting out of bed as much.  Patient denies headache, visual disturbances, nausea, vomiting, constipation, dysuria, increased peripheral swelling, focal numbness/weakness.   Hospital course as below.  Cardiology followed patient during stay.  Patient improved with medical treatment.  Patient discharged home in stable condition.  Home health care services arranged, patient declined SNF placement.   1.  COVID, +12/3: -Chest x-ray no pneumonia -Patient requiring oxygen, receiving Decadron remdesivir -Decadron -Remdesivir -Eliquis DVT prophylaxis  2.  Acute hypoxic respiratory failure: -In the setting of above -Wean oxygen as able  3.  New onset A. fib with RVR: -Cardiology following -12/3 echo EF 65%, grade 1 diastolic dysfunction -lopressor dc in setting of bradycardia -Started on Eliquis -30-day event monitor with cardiology  4.  Hypokalemia: -Replace  5.  Generalized weakness: -PT/OT -Social work for discharge needs  6. Obesity
Age: 66.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Acoustic stimulation tests normal, Facial pain, Headache, Malaise, Nasal congestion
Clinical narrative: I had off and on vertigo and Tinnitus after my COVID-19 shots. It could have always been there I am not sure. It has not impacted my hearing. I have had it tested. Recently, I had headache and nose congestion, it was really bad vertigo at first. I tend to get that first when I get sick. It was pain in my face along with the headache. I contacted my doctor yesterday the infection was not going away after trying to treat it on my own. I took two COVID-19 home tests that were negative. I got to an appointment and prescribed amoxicillin and another antibiotic. I still feel it in my face and nose, but the sinus infection is getting better.
Age: 66.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: SARS-CoV-2 test negative, Sinusitis, Tinnitus, Vertigo
Clinical narrative: I had off and on vertigo and Tinnitus after my COVID-19 shots. It could have always been there I am not sure. It has not impacted my hearing. I have had it tested. Recently, I had headache and nose congestion, it was really bad vertigo at first. I tend to get that first when I get sick. It was pain in my face along with the headache. I contacted my doctor yesterday the infection was not going away after trying to treat it on my own. I took two COVID-19 home tests that were negative. I got to an appointment and prescribed amoxicillin and another antibiotic. I still feel it in my face and nose, but the sinus infection is getting better.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Death
Clinical narrative: Patient expired 12/28/2022.
Age: 0.75
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient rec'd Covid Monovalent as 3rd dose rather than Covid Bivalent
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Asthenia, Bladder catheterisation, Blood creatinine increased, COVID-19
Clinical narrative: Patient is a 48 y.o. male with a history of primary progressive MS (on ocrevus), HTN who presented to RMH 12/7/2022 with complaints of fatigue, fever and profound weakness. He was found to have COVID infection and AKI.    1. COVID-19 Infection: Partially vaccinated, symptom onset 12/5/22, positive test 12/7/22. With sepsis on admit. Completed 5 days of paxlovid on 12/12/22.  2. Primary Progressive MS: Follows with Dr. Receives Ocrevus infusions, last 8/2022. Baseline weakness in both legs, able to ambulate. With psuedoexacerbation on admit due to COVID infection. Neurology followed with no further recommendations. PTOT recommended IPR. 3. AKI with Obstructive Nephropathy: baseline Cr 0.7, Cr up to 1.6 by 12/8/22, PVR > 800ml, Cr improved 0.8 by 12/11/22 after foley placement. Voiding trial at IPR.   4. Acute Urinary Retention: with associated AKI, required foley placement. Urology recommended to stop Oxybutynin, added Flomax and continue foley at discharge. Follow up with urology as outpatient.  5. Chronic Constipation: due to immobility, CT abdomen pelvis on admission with large stool burden. Continued bowel regimen.  6. Chronic LE Edema: due to chronic debility.  7. HTN: Continued home meds.  8. Code status: full code
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram abdomen abnormal, Constipation, Faecaloma, Fatigue, Immobile
Clinical narrative: Patient is a 48 y.o. male with a history of primary progressive MS (on ocrevus), HTN who presented to RMH 12/7/2022 with complaints of fatigue, fever and profound weakness. He was found to have COVID infection and AKI.    1. COVID-19 Infection: Partially vaccinated, symptom onset 12/5/22, positive test 12/7/22. With sepsis on admit. Completed 5 days of paxlovid on 12/12/22.  2. Primary Progressive MS: Follows with Dr. Receives Ocrevus infusions, last 8/2022. Baseline weakness in both legs, able to ambulate. With psuedoexacerbation on admit due to COVID infection. Neurology followed with no further recommendations. PTOT recommended IPR. 3. AKI with Obstructive Nephropathy: baseline Cr 0.7, Cr up to 1.6 by 12/8/22, PVR > 800ml, Cr improved 0.8 by 12/11/22 after foley placement. Voiding trial at IPR.   4. Acute Urinary Retention: with associated AKI, required foley placement. Urology recommended to stop Oxybutynin, added Flomax and continue foley at discharge. Follow up with urology as outpatient.  5. Chronic Constipation: due to immobility, CT abdomen pelvis on admission with large stool burden. Continued bowel regimen.  6. Chronic LE Edema: due to chronic debility.  7. HTN: Continued home meds.  8. Code status: full code
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Muscular weakness, Obstructive nephropathy, Oedema peripheral, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Patient is a 48 y.o. male with a history of primary progressive MS (on ocrevus), HTN who presented to RMH 12/7/2022 with complaints of fatigue, fever and profound weakness. He was found to have COVID infection and AKI.    1. COVID-19 Infection: Partially vaccinated, symptom onset 12/5/22, positive test 12/7/22. With sepsis on admit. Completed 5 days of paxlovid on 12/12/22.  2. Primary Progressive MS: Follows with Dr. Receives Ocrevus infusions, last 8/2022. Baseline weakness in both legs, able to ambulate. With psuedoexacerbation on admit due to COVID infection. Neurology followed with no further recommendations. PTOT recommended IPR. 3. AKI with Obstructive Nephropathy: baseline Cr 0.7, Cr up to 1.6 by 12/8/22, PVR > 800ml, Cr improved 0.8 by 12/11/22 after foley placement. Voiding trial at IPR.   4. Acute Urinary Retention: with associated AKI, required foley placement. Urology recommended to stop Oxybutynin, added Flomax and continue foley at discharge. Follow up with urology as outpatient.  5. Chronic Constipation: due to immobility, CT abdomen pelvis on admission with large stool burden. Continued bowel regimen.  6. Chronic LE Edema: due to chronic debility.  7. HTN: Continued home meds.  8. Code status: full code
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Sepsis, Trial of void, Urinary retention
Clinical narrative: Patient is a 48 y.o. male with a history of primary progressive MS (on ocrevus), HTN who presented to RMH 12/7/2022 with complaints of fatigue, fever and profound weakness. He was found to have COVID infection and AKI.    1. COVID-19 Infection: Partially vaccinated, symptom onset 12/5/22, positive test 12/7/22. With sepsis on admit. Completed 5 days of paxlovid on 12/12/22.  2. Primary Progressive MS: Follows with Dr. Receives Ocrevus infusions, last 8/2022. Baseline weakness in both legs, able to ambulate. With psuedoexacerbation on admit due to COVID infection. Neurology followed with no further recommendations. PTOT recommended IPR. 3. AKI with Obstructive Nephropathy: baseline Cr 0.7, Cr up to 1.6 by 12/8/22, PVR > 800ml, Cr improved 0.8 by 12/11/22 after foley placement. Voiding trial at IPR.   4. Acute Urinary Retention: with associated AKI, required foley placement. Urology recommended to stop Oxybutynin, added Flomax and continue foley at discharge. Follow up with urology as outpatient.  5. Chronic Constipation: due to immobility, CT abdomen pelvis on admission with large stool burden. Continued bowel regimen.  6. Chronic LE Edema: due to chronic debility.  7. HTN: Continued home meds.  8. Code status: full code
Age: 10.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site erythema, Injection site pruritus, Injection site rash, Injection site warmth
Clinical narrative: Vaccine administered at 1435.  Patient mother notified staff of red rash around injection site. Staff assessed rash. Rash was a red circle around the injection site. Patient was stable. Staff came and got nurse to assess patient. Nurse then assessed injection site and it was red, warm and patient states "itchy". Vital signs included BP: 105/68, Sp02: 98, Pulse: 64 at 1457. Patient denied dizziness, shortness of breath, or pain. Patient was stable. Nurse notified Dr. (Patient PCP). Patient was given ice pack and remained in room for 30 minutes after assessing the rash. Dr. assessed patient and advised patient mother to administer Benadryl at 1521. Benadryl was administered by mother from her home Benadryl.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dry throat, Headache, Nasal congestion
Clinical narrative: I had a running nose, stuffy head, dry throat, unproductive cough, and headache. I tested positive for COVID-19 at home. I talked to my doctor, and she prescribed me fluticasone and azithromycin. I still have a stuffy nose and a little cough.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: I had a running nose, stuffy head, dry throat, unproductive cough, and headache. I tested positive for COVID-19 at home. I talked to my doctor, and she prescribed me fluticasone and azithromycin. I still have a stuffy nose and a little cough.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Abdominal distension, Blood test, Gastrointestinal bacterial overgrowth, Hydrogen breath test abnormal
Clinical narrative: I have been having abdominal discomfort and distention. I went to the doctor who ran blood test, hydrogen breath test. It was found that I have a small intestine bacterial overgrowth. We are currently working on getting the bacterial overgrowth under control.
Age: 20.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Rash
Clinical narrative: Patient called following evening stating that the evening after getting both vaccines, patient broke out in all over body rash.  Patient took benadryl otc the evening of reaction and was instructed to take another dose of benadryl and if no improvement to seek medical attention.  Followed up with patient who did contact md who believed pt reaction is likely due to her recent use of amoxicillin due to patient family history of penicillin allergy but it was not concluded to be the sole cause.  Patient received additional recommendations from their doctor and is following their care.
Sex: M
Vaccine: UNK
Symptoms: Intussusception
Clinical narrative: Episodes of intussusception after first dose of rotavirus vaccine, parents were not made aware of any complications or any information about the vaccine, mom asked MD about abdominal complications with 4 month vaccine, MD stated "nothing we are giving have any abdominal complications". Baby received vaccine on Dec 19 and had first episode on Dec 24 and second episode on Dec 29. Intussusception self resolved before I could get him to the ER both times.
Age: 70.0
Sex: M
Vaccine: COVID19-2
Symptoms: Cough, Fatigue, Nasopharyngitis, Oropharyngeal pain, SARS-CoV-2 test negative
Clinical narrative: Sore throat that seemed to develop into a cold. Other symptoms went away after a few days but the sore throat and cough lasted 2 weeks.  Went to doctor when cough persisted for more than a week.  I seemed to feel better and tested negative for covid so  I went back to work.  Then felt worse again - and also continued to experience fatigue.  Feeling better by the end of November.
Age: 87.0
Sex: M
Vaccine: COVID19-2
Symptoms: Agitation, Atrial fibrillation, Blood electrolytes normal, Blood lactic acid, Bundle branch block left
Clinical narrative: Adverse event information provided in this submission, is per a report received by a Public Health Department from a submitting facility. Covid-19 vaccination information is from Immunization Registry.  Pfizer 3/15/2021 lot number not available; Pfizer  4/07/2021 lot number not available;  Pfizer 12/21/21 Lot number FE3594;  Pfizer 10/19/22 Pfizer BvlntBstr 12+  Lot number: GH9697  Per note submitted from the hospital admission date 11/20/2022. ?Multiple diagnoses were considered for this patient including but not limited to pneumonia, UTI, arrhythmia, sepsis. Clinical impression appears to be most consistent with fever secondary to COVID-19 with altered menta l status and atrial fibrillation. Patient presents with subjective fevers and chills per the wife at home. Increased confusion and agitation today. Does have a history of dementia and i s normally confused. Per the wife he is essentially at his baseline but was slightly more agitated today. She noted that he felt warm at home and was shaking as though he was having chills. No temperatures measured at home. Here his lungs are clear and his urine is clean. White blood cell count is normal. Lactic acid is 1.8 and so below 2. Does not meet criteria for severe sepsis. No evidence of hypotension to suggest septic shock. Oxygenating normally. EKG shows what appears to be rate controlled atrial fibrillation which I cannot find a history of. There are no ischemic changes although he does have a more noticeable left bundle branch block on today's EKG when compared to previous. His troponin is normal. Thyroid function is normal. Electrolyte's and renal function are normal. Patient's C OVID swab did come back positive for COVID. I think this is likely the source of his fever. Given his age and risk factors and potential new A. fib I think admission for further evaluation is warranted. He is admitted in stable condition on 11/20/2022.?  No further information is known on the outcome of this patient. Please contact provider for any additional information.
Age: 87.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Chills, Condition aggravated, Confusional state, Electrocardiogram abnormal
Clinical narrative: Adverse event information provided in this submission, is per a report received by a Public Health Department from a submitting facility. Covid-19 vaccination information is from Immunization Registry.  Pfizer 3/15/2021 lot number not available; Pfizer  4/07/2021 lot number not available;  Pfizer 12/21/21 Lot number FE3594;  Pfizer 10/19/22 Pfizer BvlntBstr 12+  Lot number: GH9697  Per note submitted from the hospital admission date 11/20/2022. ?Multiple diagnoses were considered for this patient including but not limited to pneumonia, UTI, arrhythmia, sepsis. Clinical impression appears to be most consistent with fever secondary to COVID-19 with altered menta l status and atrial fibrillation. Patient presents with subjective fevers and chills per the wife at home. Increased confusion and agitation today. Does have a history of dementia and i s normally confused. Per the wife he is essentially at his baseline but was slightly more agitated today. She noted that he felt warm at home and was shaking as though he was having chills. No temperatures measured at home. Here his lungs are clear and his urine is clean. White blood cell count is normal. Lactic acid is 1.8 and so below 2. Does not meet criteria for severe sepsis. No evidence of hypotension to suggest septic shock. Oxygenating normally. EKG shows what appears to be rate controlled atrial fibrillation which I cannot find a history of. There are no ischemic changes although he does have a more noticeable left bundle branch block on today's EKG when compared to previous. His troponin is normal. Thyroid function is normal. Electrolyte's and renal function are normal. Patient's C OVID swab did come back positive for COVID. I think this is likely the source of his fever. Given his age and risk factors and potential new A. fib I think admission for further evaluation is warranted. He is admitted in stable condition on 11/20/2022.?  No further information is known on the outcome of this patient. Please contact provider for any additional information.
Age: 87.0
Sex: M
Vaccine: COVID19-2
Symptoms: Laboratory test, Mental status changes, Pyrexia, Renal function test normal, SARS-CoV-2 test positive
Clinical narrative: Adverse event information provided in this submission, is per a report received by a Public Health Department from a submitting facility. Covid-19 vaccination information is from Immunization Registry.  Pfizer 3/15/2021 lot number not available; Pfizer  4/07/2021 lot number not available;  Pfizer 12/21/21 Lot number FE3594;  Pfizer 10/19/22 Pfizer BvlntBstr 12+  Lot number: GH9697  Per note submitted from the hospital admission date 11/20/2022. ?Multiple diagnoses were considered for this patient including but not limited to pneumonia, UTI, arrhythmia, sepsis. Clinical impression appears to be most consistent with fever secondary to COVID-19 with altered menta l status and atrial fibrillation. Patient presents with subjective fevers and chills per the wife at home. Increased confusion and agitation today. Does have a history of dementia and i s normally confused. Per the wife he is essentially at his baseline but was slightly more agitated today. She noted that he felt warm at home and was shaking as though he was having chills. No temperatures measured at home. Here his lungs are clear and his urine is clean. White blood cell count is normal. Lactic acid is 1.8 and so below 2. Does not meet criteria for severe sepsis. No evidence of hypotension to suggest septic shock. Oxygenating normally. EKG shows what appears to be rate controlled atrial fibrillation which I cannot find a history of. There are no ischemic changes although he does have a more noticeable left bundle branch block on today's EKG when compared to previous. His troponin is normal. Thyroid function is normal. Electrolyte's and renal function are normal. Patient's C OVID swab did come back positive for COVID. I think this is likely the source of his fever. Given his age and risk factors and potential new A. fib I think admission for further evaluation is warranted. He is admitted in stable condition on 11/20/2022.?  No further information is known on the outcome of this patient. Please contact provider for any additional information.
Age: 87.0
Sex: M
Vaccine: COVID19-2
Symptoms: Skin warm, Thyroid function test normal, Tremor, Troponin normal, Urine analysis normal
Clinical narrative: Adverse event information provided in this submission, is per a report received by a Public Health Department from a submitting facility. Covid-19 vaccination information is from Immunization Registry.  Pfizer 3/15/2021 lot number not available; Pfizer  4/07/2021 lot number not available;  Pfizer 12/21/21 Lot number FE3594;  Pfizer 10/19/22 Pfizer BvlntBstr 12+  Lot number: GH9697  Per note submitted from the hospital admission date 11/20/2022. ?Multiple diagnoses were considered for this patient including but not limited to pneumonia, UTI, arrhythmia, sepsis. Clinical impression appears to be most consistent with fever secondary to COVID-19 with altered menta l status and atrial fibrillation. Patient presents with subjective fevers and chills per the wife at home. Increased confusion and agitation today. Does have a history of dementia and i s normally confused. Per the wife he is essentially at his baseline but was slightly more agitated today. She noted that he felt warm at home and was shaking as though he was having chills. No temperatures measured at home. Here his lungs are clear and his urine is clean. White blood cell count is normal. Lactic acid is 1.8 and so below 2. Does not meet criteria for severe sepsis. No evidence of hypotension to suggest septic shock. Oxygenating normally. EKG shows what appears to be rate controlled atrial fibrillation which I cannot find a history of. There are no ischemic changes although he does have a more noticeable left bundle branch block on today's EKG when compared to previous. His troponin is normal. Thyroid function is normal. Electrolyte's and renal function are normal. Patient's C OVID swab did come back positive for COVID. I think this is likely the source of his fever. Given his age and risk factors and potential new A. fib I think admission for further evaluation is warranted. He is admitted in stable condition on 11/20/2022.?  No further information is known on the outcome of this patient. Please contact provider for any additional information.
Age: 87.0
Sex: M
Vaccine: COVID19-2
Symptoms: White blood cell count normal
Clinical narrative: Adverse event information provided in this submission, is per a report received by a Public Health Department from a submitting facility. Covid-19 vaccination information is from Immunization Registry.  Pfizer 3/15/2021 lot number not available; Pfizer  4/07/2021 lot number not available;  Pfizer 12/21/21 Lot number FE3594;  Pfizer 10/19/22 Pfizer BvlntBstr 12+  Lot number: GH9697  Per note submitted from the hospital admission date 11/20/2022. ?Multiple diagnoses were considered for this patient including but not limited to pneumonia, UTI, arrhythmia, sepsis. Clinical impression appears to be most consistent with fever secondary to COVID-19 with altered menta l status and atrial fibrillation. Patient presents with subjective fevers and chills per the wife at home. Increased confusion and agitation today. Does have a history of dementia and i s normally confused. Per the wife he is essentially at his baseline but was slightly more agitated today. She noted that he felt warm at home and was shaking as though he was having chills. No temperatures measured at home. Here his lungs are clear and his urine is clean. White blood cell count is normal. Lactic acid is 1.8 and so below 2. Does not meet criteria for severe sepsis. No evidence of hypotension to suggest septic shock. Oxygenating normally. EKG shows what appears to be rate controlled atrial fibrillation which I cannot find a history of. There are no ischemic changes although he does have a more noticeable left bundle branch block on today's EKG when compared to previous. His troponin is normal. Thyroid function is normal. Electrolyte's and renal function are normal. Patient's C OVID swab did come back positive for COVID. I think this is likely the source of his fever. Given his age and risk factors and potential new A. fib I think admission for further evaluation is warranted. He is admitted in stable condition on 11/20/2022.?  No further information is known on the outcome of this patient. Please contact provider for any additional information.
Age: 59.0
Sex: M
Vaccine: FLU4
Symptoms: Death, Musculoskeletal stiffness, Nasopharyngitis, Pain, Tenderness
Clinical narrative: Patient received vaccine 12/21/22; patient's sister reported to the pharmacy 12/29/22 that the patient was discovered deceased the morning of 12/29/22.  She said the patient had a slight cold the day he was given the vaccine and had local tenderness of his arm after vaccination.  She stated that the evening of 12/28/22 he complained of pain / stiffness in his whole body.  She stated that she believes the vaccine was responsible for patient's death.
Age: 49.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Chills, Cough, Impaired work ability, Influenza virus test negative
Clinical narrative: On 12/13/2022, I was having a cough, sore throat, and chills. I didn't have any fever yet, but still had the chills. I was also having body aches. The next day, the symptoms were the same and I was unable to work. I went to a local urgent care because I could not get an appointment with my doctor. They tested me for COVID-19, Strep, and Flu. I was positive for COVID-19. They prescribed benzoate and BROMFED DM. After beginning the medication, I was feeling better by Friday. By that Saturday, everything was gone except for the cough. I still have a bit of the cough today. I visited the urgent care clinic again yesterday. They informed me that I may have these symptoms for 6-8 weeks. They advised that I continue the medication, but to lower the dosage.
Age: 49.0
Sex: M
Vaccine: COVID19-2
Symptoms: Oropharyngeal pain, Pain, SARS-CoV-2 test positive, Streptococcus test negative, Urine analysis normal
Clinical narrative: On 12/13/2022, I was having a cough, sore throat, and chills. I didn't have any fever yet, but still had the chills. I was also having body aches. The next day, the symptoms were the same and I was unable to work. I went to a local urgent care because I could not get an appointment with my doctor. They tested me for COVID-19, Strep, and Flu. I was positive for COVID-19. They prescribed benzoate and BROMFED DM. After beginning the medication, I was feeling better by Friday. By that Saturday, everything was gone except for the cough. I still have a bit of the cough today. I visited the urgent care clinic again yesterday. They informed me that I may have these symptoms for 6-8 weeks. They advised that I continue the medication, but to lower the dosage.